Analyst firms · H.C. Wainwright · IMUX
H.C. Wainwright IMUX price target and rating history
Immunic Inc. (IMUX) · Health Care
H.C. Wainwright rates Immunic Inc. (IMUX) Buy with a $10 price target, as of its latest action on Nov 25, 2024. It has published 3 rating actions on IMUX since September 2021, including 0 upgrades and 0 downgrades. Across 3 firms with a IMUX price target in the last 12 months, the median target is $7.
- Current rating
- Buy
- Price target
- $10
- Median target, all firms
- $7
- Actions on IMUX
- 3
H.C. Wainwright price target on IMUX
Every H.C. Wainwright rating on IMUX
- Nov 25, 2024
- Sep 19, 2022
- Sep 7, 2021
How other firms rate IMUX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Cantor Fitzgerald | Overweight | Oct 23, 2026 | |
| Wedbush | Outperform | $45 | Aug 17, 2026 |
| Wolfe Research | Outperform | May 22, 2026 | |
| Stifel | Buy | $2.50 | Apr 17, 2026 |
| D. Boral Capital | Hold | Apr 15, 2026 | |
| Guggenheim | Buy | $7 | Mar 24, 2026 |
Questions about H.C. Wainwright and IMUX
- What is H.C. Wainwright's price target for IMUX?
- H.C. Wainwright's latest stated price target for Immunic Inc. (IMUX) is $10, from its action on Nov 25, 2024.
- What is H.C. Wainwright's rating on IMUX?
- H.C. Wainwright rates IMUX Buy, a bullish rating, as of Nov 25, 2024.
- When did H.C. Wainwright last change its view on IMUX?
- On Nov 25, 2024, H.C. Wainwright starts coverage at Buy, price target $10.
- How does H.C. Wainwright's IMUX target compare with other analysts?
- Across 3 firms with a IMUX price target in the last 12 months, the median target is $7.
All H.C. Wainwright ratingsIMUX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.